Following Mitochondrial Footprints through a Long Mucosal Path to Lung Cancer
Open Access
- 6 August 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (8) , e6533
Abstract
Mitochondrial DNA (mtDNA) mutations are reported in different tumors. However, there is no information on the temporal development of the mtDNA mutations/content alteration and their extent in normal and abnormal mucosa continuously exposed to tobacco smoke in lung cancer patients. We examined the pattern of mtDNA alteration (mtDNA mutation and content index) in 25 airway mucosal biopsies, corresponding tumors and normal lymph nodes obtained from three patients with primary lung cancers. In addition, we examined the pattern of mtDNA mutation in corresponding tumors and normal lymph nodes obtained from eight other patients with primary lung cancers. The entire 16.5 kb mitochondrial genome was sequenced on Affymetrix Mitochip v2.0 sequencing platform in every sample. To examine mtDNA content index, we performed real-time PCR analysis. The airway mucosal biopsies obtained from three lung cancer patients were histopathologically negative but exhibited multiple clonal mtDNA mutations detectable in the corresponding tumors. One of the patients was operated twice for the removal of tumor from the right upper and left lower lobe respectively within a span of two years. Both of these tumors exhibited twenty identical mtDNA mutations. MtDNA content increased significantly (P<0.001) in the lung cancer and all the histologically negative mucosal biopsies except one compared to the control lymph node. Our results document the extent of massive clonal patches that develop in lifetime smokers and ultimately give rise to clinically significant cancers. These observations shed light on the extent of disease in the airway of smokers traceable through mtDNA mutation. MtDNA mutation could be a reliable tool for molecular assessment of respiratory epithelium exposed to continuous smoke as well as disease detection and monitoring. Functional analysis of the pathogenic mtDNA mutations may be useful to understand their role in lung tumorigenesis.Keywords
This publication has 27 references indexed in Scilit:
- Performance of mitochondrial DNA mutations detecting early stage cancerBMC Cancer, 2008
- Concomitant presence of mutations in mitochondrial genome and p53 in cancer development—A study in north Indian sporadic breast and esophageal cancer patientsInternational Journal of Cancer, 2008
- ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell MetastasisScience, 2008
- Multiple strand displacement amplification of mitochondrial DNA from clinical samplesBMC Medical Genetics, 2008
- Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumorsProceedings of the National Academy of Sciences, 2007
- Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neckProceedings of the National Academy of Sciences, 2007
- An Oligonucleotide Microarray for High-Throughput Sequencing of the Mitochondrial GenomeThe Journal of Molecular Diagnostics, 2006
- Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fissionProceedings of the National Academy of Sciences, 2006
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- Increased Mitochondrial DNA Content in Saliva Associated with Head and Neck CancerClinical Cancer Research, 2005